Home>REGULATORY

Payer Rep Insists CEA-Based Price Hike “Not an Option,” MHLW Wants “Grounds” for That Argument: Chuikyo(Oct.26.2017)
Medical Economics Division Director Masami Sakoi Preparing for Chuikyo CEA Joint Meeting |
As a vocal payer member of a key reimbursement policy panel continues to stand against a possible price raise under an as-yet-elusive cost-effective assessment scheme in Japan, a health ministry official chafed at his refusal on October 25, asking for “grounds” for his argument ...
(LOG IN FOR FULL STORY)
- Japan Trains Sight on CEA as Centerpiece of This Year’s Cost Containment Efforts Apr.23
- Label Revision Ordered for Keytruda with Sclerosing Cholangitis as ADR Apr.20
- MHLW Sees Solid Inquiry Numbers for Conditional Early Approval System: Official Apr.19
- Generic Industry Asks for Govt Support for Continuous Manufacturing to Boost Int’l Competitiveness: Public-Private Confab Apr.17
- No Company Supports New Price Maintenance Premium Scheme: FPMAJ Survey Apr.17